A Study of Lebrikizumab (LY3650150) on Vaccine Response in Adults With Atopic Dermatitis (ADopt-VA)

PHASE3CompletedINTERVENTIONAL
Enrollment

254

Participants

Timeline

Start Date

November 17, 2020

Primary Completion Date

August 3, 2022

Study Completion Date

September 30, 2022

Conditions
Atopic Dermatitis
Interventions
DRUG

Lebrikizumab

Given SC

DRUG

Placebo

Given SC

Trial Locations (85)

15213

University of Pittsburgh Medical Center, Pittsburgh

15241

Peak Research LLC, Upper Saint Clair

19104

University of Pennsylvania Hospital, Philadelphia

29425

Medical University of South Carolina, Charleston

30328

Advanced Medical Research, Sandy Springs

31419

Georgia Skin & Cancer Clinic, Savannah

32256

Solutions Through Advanced Research, Jacksonville

33012

Direct Helpers Research Center, Hialeah

33016

The Community Research of South Florida, Hialeah

Wellness Clinical Research, Miami Lakes

33028

Riverchase Dermatology and Cosmetic Surgery, Pembroke Pines

33134

Florida Academic Centers Research and Education, LLC, Coral Gables

33144

International Dermatology Research, Inc., Miami

33157

Sanchez Clinical Research Inc, Miami

33165

New Horizon Research Center, Miami

33173

Miami Dermatology and Laser Research, Miami

33174

Florida Research Center, Inc, Miami

33183

C&R Research Services USA, Kendall

33612

Tampa General Hospital, Tampa

33614

Olympian Clinical Research, Tampa

35244

Clinical Research Center of Alabama- Birmingham, Birmingham

40217

Skin Sciences, PLLC, Louisville

44106

University Hospitals Case Medical Center, Cleveland

45414

Ohio Pediatric Research Association, Dayton

46168

The Indiana Clinical Trials Center, Plainfield

48088

Grekin Skin Institute, Warren

48326

Oakland Dermatology, Auburn Hills

60118

Dundee Dermatology, West Dundee

61761

Sneeze, Wheeze, & Itch Associates LLC, Normal

64506

MediSearch Clinical Trials, Saint Joseph

66215

Kansas City Dermatology, PA, Overland Park

66216

Kansas Medical Clinic, an Elligo Health Research, Inc., Shawnee Mission

66614

Kansas Medical Clinic, Topeka

68144

Advanced Dermatology of the Midlands, Omaha

70112

Tulane Univ School of Med, New Orleans

71913

Burke Pharmaceutical Research, Hot Springs

72117

Arkansas Research Trials, North Little Rock

73118

Unity Clinical Research, Oklahoma City

74136

Central States Research, Tulsa

Vital Prospects Clinical Research Institute, PC, Tulsa

75230

Dermatology Treatment and Research Center, Dallas

75231

Modern Research Associates, Dallas

76011

Arlington Research Center, Inc, Arlington

77004

Center for Clinical Studies, Houston

77056

Suzanne Bruce and Associates, PA, Houston

77401

Bellaire Dermatology Associates, Bellaire

77598

Center for Clinical Studies, Webster

78041

Laredo Dermatology Associates P.A., Laredo

78213

Progressive Clinical Research, San Antonio

78218

Texas Dermatology and Laser Specialists, San Antonio

78620

Austin Institute for Clinical Research, Dripping Springs

80112

IMMUNOe International Research Centers, Centennial

84095

Jordan Valley Dermatology Center, South Jordan

84117

Velocity Clinical Research - Woseth Dermatology, Salt Lake City

90033

Keck School of Medicine University of Southern California, Los Angeles

90045

Dermatology Research Associates, Los Angeles

90057

LA Universal Research Center, INC, Los Angeles

90211

Wallace Medical Group, Inc., Beverly Hills

90266

Ablon Skin Institute and Research Center, Manhattan Beach

90301

Axon Clinical Research, Inglewood

92119

MD Strategies Research Centers MDSRC, San Diego

92123

University Clinical Trials, San Diego

92660

Dermatology Clinical Trials, Newport Beach

92677

Avance Trials, Laguna Niguel

92701

Southern California Dermatology, Inc., Santa Ana

92708

First OC Dermatology, Fountain Valley

92801

Orange County Research Institute, Anaheim

93405

San Luis Dermatology & Laser Clinic, San Luis Obispo

93551

Cura Clinical Research, Palmdale

94132

Synergy Dermatology, San Francisco

94538

Center For Dermatology Clinical Research, Inc., Fremont

94549

Sunwise Clinical Research, Lafayette

95117

Care Access Research, San Jose

97223

Oregon Medical Research Center, Portland

99202

Premier Clinical Research, Spokane

80907-6231

Asthma and Allergy Associates, PC, Colorado Springs

33613-1244

ForCare Clinical Research, Tampa

02111

Tufts Medical Center, Boston

02115

Brigham and Women's Hospital, Boston

02135

Metro Boston Clinical Partners, Brighton

08520

Psoriasis Treatment Center of Central New Jersey, East Windsor

07601

Skin Laser and Surgery Specialists, a Division of Schweiger Dermatology, Hackensack

10022-3350

JUVA Skin & Laser Center, New York

02919

Clinical Partners, LLC, Johnston

02886

AAPRI Clinical Research Institute, Warwick

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT04626297 - A Study of Lebrikizumab (LY3650150) on Vaccine Response in Adults With Atopic Dermatitis (ADopt-VA) | Biotech Hunter | Biotech Hunter